|
89 Companies |
|
65 Products |
|
65 Products |
|
50 Mechanisms of Action |
|
817 Trials |
|
63690 News |
|
| «12...701702703704705706707708709710711712713» |
- ||| Lumigan (bimatoprost) / Senju, AbbVie
Clinical: Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (clinicaltrials.gov) - Jun 25, 2012
P=N/A, N=854, Completed, Sponsor: Allergan
- Enrollment closed: Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy (clinicaltrials.gov) - Jun 10, 2012
P=N/A, N=54, Active, not recruiting, Sponsor: University of Toronto
Recruiting --> Active, not recruiting
- Enrollment open: DSLT: Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma (clinicaltrials.gov) - Jun 9, 2012
P=N/A, N=20, Recruiting, Sponsor: Sheba Medical Center
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | timolol maleate ophthalmic solution / Generic mfg., travoprost ophthalmic / Generic mfg.
Trial completion, Monotherapy: Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol (clinicaltrials.gov) - Jun 6, 2012
P4, N=50, Completed, Sponsor: Alcon Research
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||||||| Taptiqom (tafluprost/timolol) / Santen, AGC Biologics
Trial completion, Head-to-Head: Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations (clinicaltrials.gov) - Jun 6, 2012
P3, N=401, Completed, Sponsor: Santen Oy
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| Enrollment change: Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - Jun 5, 2012
P3, N=160, Completed, Sponsor: Sun Pharma Advanced Research Company Limited
Active, not recruiting --> Completed N=200 --> 160
- ||||||| Trial completion: Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - Jun 5, 2012
P3, N=590, Completed, Sponsor: Sun Pharma Advanced Research Company Limited
N=200 --> 160 Recruiting --> Completed
- ||||||| Trial completion: Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - Jun 5, 2012
P3, N=160, Completed, Sponsor: Sun Pharma Advanced Research Company Limited
Recruiting --> Completed Recruiting --> Completed
- Trial withdrawal: Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy (clinicaltrials.gov) - Jun 4, 2012
P=N/A, N=0, Withdrawn, Sponsor: Sooft Italia
Recruiting --> Completed Not yet recruiting --> Withdrawn
- Trial withdrawal: Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye Drops (clinicaltrials.gov) - Jun 4, 2012
P=N/A, N=0, Withdrawn, Sponsor: Sooft Italia
Not yet recruiting --> Withdrawn Not yet recruiting --> Withdrawn
- Enrollment change: Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy (clinicaltrials.gov) - Jun 4, 2012
P=N/A, N=0, Withdrawn, Sponsor: Sooft Italia
Not yet recruiting --> Withdrawn N=60 --> 0
- Enrollment change: Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye Drops (clinicaltrials.gov) - Jun 4, 2012
P=N/A, N=0, Withdrawn, Sponsor: Sooft Italia
N=60 --> 0 N=130 --> 0
- | Combigan (brimonidine tartrate/timolol maleate) / AbbVie
Trial completion: Circadian Ocular Perfusion Pressure and Ocular Blood Flow (clinicaltrials.gov) - Jun 3, 2012
P4, N=35, Completed, Sponsor: Alcon Research
N=130 --> 0 Recruiting --> Completed
- Retisert (fluocinolone acetonide intravitreal implant) / Bausch Health, EyePoint Pharma
Enrollment change: Prophylactic Anecortave Acetate in Patients With a Retisert Implant (clinicaltrials.gov) - Jun 2, 2012
P1, N=12, Completed, Sponsor: Texas Retina Associates
Recruiting --> Completed N=24 --> 12
- | Retisert (fluocinolone acetonide intravitreal implant) / Bausch Health, EyePoint Pharma
Trial completion: Prophylactic Anecortave Acetate in Patients With a Retisert Implant (clinicaltrials.gov) - Jun 2, 2012
P1, N=12, Completed, Sponsor: Texas Retina Associates
N=24 --> 12 Active, not recruiting --> Completed
- |||| Lumigan (bimatoprost) / Senju, AbbVie
Trial completion: Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN (clinicaltrials.gov) - May 31, 2012
P4, N=84, Completed, Sponsor: Alcon Research
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
Trial completion: Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2% (clinicaltrials.gov) - May 31, 2012
P3, N=1062, Completed, Sponsor: Alcon Research
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial withdrawal: A Multi-Dose Study With a Treatment for Open-Angle Glaucoma (clinicaltrials.gov) - May 28, 2012
P2/3, N=0, Withdrawn, Sponsor: Alcon Research
Active, not recruiting --> Completed Terminated --> Withdrawn
- Enrollment change: A Multi-Dose Study With a Treatment for Open-Angle Glaucoma (clinicaltrials.gov) - May 28, 2012
P2/3, N=0, Withdrawn, Sponsor: Alcon Research
Terminated --> Withdrawn N=400 --> 0
- |||| Trial completion: AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure (clinicaltrials.gov) - May 28, 2012
P4, N=74, Completed, Sponsor: Alcon Research
N=400 --> 0 Recruiting --> Completed
- ||| timolol maleate ophthalmic solution / Generic mfg., travoprost ophthalmic / Generic mfg.
Enrollment change, Adherence: GAS: Glaucoma Adherence Study (clinicaltrials.gov) - May 27, 2012
P4, N=55, Completed, Sponsor: Alcon Research
Recruiting --> Completed N=100 --> 55
- Trial completion: IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic (clinicaltrials.gov) - May 21, 2012
P=N/A, N=43, Completed, Sponsor: University of Nebraska
N=100 --> 55 Recruiting --> Completed
- |||| travoprost ophthalmic / Generic mfg.
Trial completion: AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure (clinicaltrials.gov) - May 14, 2012
P2, N=93, Completed, Sponsor: Aerie Pharmaceuticals
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| bimatoprost/brimonidine/timolol / AbbVie
Enrollment change, Combination therapy: Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - May 13, 2012
P3, N=184, Recruiting, Sponsor: Allergan
Active, not recruiting --> Completed N=146 --> 184
- |||| Lumigan (bimatoprost) / Senju, AbbVie
Trial completion: Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - May 13, 2012
P2, N=125, Completed, Sponsor: Allergan
N=146 --> 184 Active, not recruiting --> Completed
- |||| Lumigan (bimatoprost) / Senju, AbbVie
Trial completion: Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (clinicaltrials.gov) - May 13, 2012
P2, N=163, Completed, Sponsor: Allergan
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| Lumigan (bimatoprost) / Senju, AbbVie
New P4 trial: A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH) (clinicaltrials.gov) - May 7, 2012
P4, N=800, Completed, Sponsor: Allergan
- |||| Trial completion: ELAZOP Switching Study in Korea (clinicaltrials.gov) - May 5, 2012
P4, N=96, Completed, Sponsor: Alcon Research
Active, not recruiting --> Completed Recruiting --> Completed
- ||||| New P4 trial: Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU) (clinicaltrials.gov) - May 3, 2012
P4, N=100, Recruiting, Sponsor: EyeTechCare
- ||||||| Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
Trial completion: Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% (clinicaltrials.gov) - May 3, 2012
P3, N=1001, Completed, Sponsor: Alcon Research
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Effect of Nitrous Oxide (N2O) on Intraocular Pressure in Healthy Volunteers (clinicaltrials.gov) - May 2, 2012
P4, N=20, Completed, Sponsor: Oregon Health and Science University
Active, not recruiting --> Completed Enrolling by invitation --> Completed
- |||| latanoprost / Generic mfg.
Trial completion: Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated (clinicaltrials.gov) - May 1, 2012
P4, N=81, Completed, Sponsor: Allergan
Enrolling by invitation --> Completed Active, not recruiting --> Completed
- ||||||| Trial completion: Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (clinicaltrials.gov) - Apr 26, 2012
P3, N=561, Completed, Sponsor: Allergan
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Zioptan (tafluprost) / Santen, Merck (MSD)
Trial termination: Use of an Ocular Telemetry Sensor in Tafluprost Treated Patients (clinicaltrials.gov) - Apr 24, 2012
P4, N=15, Terminated, Sponsor: Sensimed AG
Active, not recruiting --> Completed Recruiting --> Terminated
- | latanoprost / Generic mfg.
New P4 trial: Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma (clinicaltrials.gov) - Apr 16, 2012
P4, N=120, Recruiting, Sponsor: University of Cantanzaro
- | mitomycin / Generic mfg.
Enrollment change, Surgery: Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery (clinicaltrials.gov) - Mar 31, 2012
P4, N=20, Completed, Sponsor: Pro Top & Mediking Company Limited
Recruiting --> Terminated N=40 --> 20
- | mitomycin / Generic mfg.
Trial completion, Surgery: Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery (clinicaltrials.gov) - Mar 31, 2012
P4, N=20, Completed, Sponsor: Pro Top & Mediking Company Limited
N=40 --> 20 Recruiting --> Completed
- ||||| latanoprost / Generic mfg., travoprost ophthalmic / Generic mfg.
Enrollment change: Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health (clinicaltrials.gov) - Mar 29, 2012
P3, N=705, Completed, Sponsor: Alcon Research
Recruiting --> Completed N=1100 --> 705
- ||| latanoprost / Generic mfg., travoprost ophthalmic / Generic mfg.
Enrollment change: Effects of Travatan Z and Xalatan on Ocular Surface Health (clinicaltrials.gov) - Mar 29, 2012
P4, N=231, Completed, Sponsor: Alcon Research
N=1100 --> 705 N=110 --> 231
- Surgery: The Effect of Two Different Artificial Respiration Methods on the Intraocular Pressure During Surgery Under General Anesthesia (clinicaltrials.gov) - Mar 28, 2012
P=N/A, N=50, Not yet recruiting, Sponsor: Western Galilee Hospital-Nahariya
- Trial completion: PSOCT: Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis (clinicaltrials.gov) - Mar 25, 2012
P=N/A, N=85, Completed, Sponsor: Courtney Frazier Swaney
N=110 --> 231 Recruiting --> Completed
- | New P2 trial: Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage Implant (clinicaltrials.gov) - Mar 22, 2012
P2, N=55, Active, not recruiting, Sponsor: InnFocus LLC
- | Lumigan (bimatoprost) / Senju, AbbVie
New P4 trial: Comparison between the effects on ocular pressure of Bimatoprost 0.01% and Timolol 0.5% during the day and night Confronto tra gli effetti sulla pressione degli occhi del Bimatoprost 0.01% e Timololo 0.5% di giorno e di notte (EUDRACT) - Mar 19, 2012
P4, N=40, Ongoing, Sponsor: IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS
- dorzolamide/timolol / Generic mfg.
Trial withdrawal: Xal-Cos: The Effects of Cosopt (clinicaltrials.gov) - Mar 14, 2012
P=N/A, N=0, Withdrawn, Sponsor: Meir Medical Center
Recruiting --> Completed Recruiting --> Withdrawn
- dorzolamide/timolol / Generic mfg.
Enrollment change: Xal-Cos: The Effects of Cosopt (clinicaltrials.gov) - Mar 14, 2012
P=N/A, N=0, Withdrawn, Sponsor: Meir Medical Center
Recruiting --> Withdrawn N=16 --> 0
- | Lucentis (ranibizumab) / Roche, Novartis
New P2 trial: The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema (clinicaltrials.gov) - Mar 13, 2012
P2, N=20, Recruiting, Sponsor: Moorfields Eye Hospital NHS Foundation Trust
- |||||||||| New P2/3 trial: Shunt Tube Exposure Prevention Study (clinicaltrials.gov) - Mar 8, 2012
P2/3, N=96, Recruiting, Sponsor: Tissue Tech Inc.
- ||||| Lumigan (bimatoprost) / Senju, AbbVie
New P4 trial: Safety and Efficacy of LUMIGAN (clinicaltrials.gov) - Mar 6, 2012
P4, N=134, Completed, Sponsor: Allergan
- ||||| dorzolamide/timolol / Generic mfg., travoprost ophthalmic / Generic mfg.
Enrollment change: A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - Mar 1, 2012
P3, N=319, Completed, Sponsor: Alcon Research
N=16 --> 0 N=450 --> 319
- Enrollment change, Surgery: Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India (clinicaltrials.gov) - Feb 28, 2012
P3, N=10, Completed, Sponsor: Pro Top & Mediking Company Limited
N=450 --> 319 N=20 --> 10